The Role of Microsimulation Modeling in Evaluating the Outcomes and Effect of Screening

Clyde B. Schechter, Nicolien T. Van Ravesteyn

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Microsimulation modeling was introduced to the social sciences in the 1950s, but did not play any significant role in health care until the 1980s. The rapid growth and plunging cost of computing power in that era supported a sustained penetration of simulation modeling into health services research and policy analysis. In this chapter we provide an overview of how modeling of breast cancer screening is done and review how microsimulations have been used to interpret and understand the results of clinical trials and observational studies, to project results of modifying screening programs and to estimate cost-effectiveness. The limitations of modeling as a method of gaining reliable information are reviewed; the most important potential sources of uncertainty, and how they are dealt with, are discussed. New applications of microsimulation in the field of breast cancer control are mentioned as possible future directions.

Original languageEnglish (US)
Title of host publicationBreast Cancer Screening: An Examination of Scientific Evidence
PublisherElsevier Inc.
Pages103-132
Number of pages30
ISBN (Print)9780128024942, 9780128022092
DOIs
StatePublished - Apr 5 2016

Fingerprint

Breast Neoplasms
Social Sciences
Policy Making
Health Services Research
Health Policy
Early Detection of Cancer
Uncertainty
Cost-Benefit Analysis
Observational Studies
Clinical Trials
Delivery of Health Care
Costs and Cost Analysis
Growth
Power (Psychology)
Clinical Studies
Direction compound

Keywords

  • Breast cancer
  • Health policy analysis
  • Health services research
  • Mammography
  • Microsimulation model
  • Screening

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Schechter, C. B., & Van Ravesteyn, N. T. (2016). The Role of Microsimulation Modeling in Evaluating the Outcomes and Effect of Screening. In Breast Cancer Screening: An Examination of Scientific Evidence (pp. 103-132). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-802209-2.00005-X

The Role of Microsimulation Modeling in Evaluating the Outcomes and Effect of Screening. / Schechter, Clyde B.; Van Ravesteyn, Nicolien T.

Breast Cancer Screening: An Examination of Scientific Evidence. Elsevier Inc., 2016. p. 103-132.

Research output: Chapter in Book/Report/Conference proceedingChapter

Schechter, CB & Van Ravesteyn, NT 2016, The Role of Microsimulation Modeling in Evaluating the Outcomes and Effect of Screening. in Breast Cancer Screening: An Examination of Scientific Evidence. Elsevier Inc., pp. 103-132. https://doi.org/10.1016/B978-0-12-802209-2.00005-X
Schechter CB, Van Ravesteyn NT. The Role of Microsimulation Modeling in Evaluating the Outcomes and Effect of Screening. In Breast Cancer Screening: An Examination of Scientific Evidence. Elsevier Inc. 2016. p. 103-132 https://doi.org/10.1016/B978-0-12-802209-2.00005-X
Schechter, Clyde B. ; Van Ravesteyn, Nicolien T. / The Role of Microsimulation Modeling in Evaluating the Outcomes and Effect of Screening. Breast Cancer Screening: An Examination of Scientific Evidence. Elsevier Inc., 2016. pp. 103-132
@inbook{0d2f727f3062448d9263b82cf7b49aad,
title = "The Role of Microsimulation Modeling in Evaluating the Outcomes and Effect of Screening",
abstract = "Microsimulation modeling was introduced to the social sciences in the 1950s, but did not play any significant role in health care until the 1980s. The rapid growth and plunging cost of computing power in that era supported a sustained penetration of simulation modeling into health services research and policy analysis. In this chapter we provide an overview of how modeling of breast cancer screening is done and review how microsimulations have been used to interpret and understand the results of clinical trials and observational studies, to project results of modifying screening programs and to estimate cost-effectiveness. The limitations of modeling as a method of gaining reliable information are reviewed; the most important potential sources of uncertainty, and how they are dealt with, are discussed. New applications of microsimulation in the field of breast cancer control are mentioned as possible future directions.",
keywords = "Breast cancer, Health policy analysis, Health services research, Mammography, Microsimulation model, Screening",
author = "Schechter, {Clyde B.} and {Van Ravesteyn}, {Nicolien T.}",
year = "2016",
month = "4",
day = "5",
doi = "10.1016/B978-0-12-802209-2.00005-X",
language = "English (US)",
isbn = "9780128024942",
pages = "103--132",
booktitle = "Breast Cancer Screening: An Examination of Scientific Evidence",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - The Role of Microsimulation Modeling in Evaluating the Outcomes and Effect of Screening

AU - Schechter, Clyde B.

AU - Van Ravesteyn, Nicolien T.

PY - 2016/4/5

Y1 - 2016/4/5

N2 - Microsimulation modeling was introduced to the social sciences in the 1950s, but did not play any significant role in health care until the 1980s. The rapid growth and plunging cost of computing power in that era supported a sustained penetration of simulation modeling into health services research and policy analysis. In this chapter we provide an overview of how modeling of breast cancer screening is done and review how microsimulations have been used to interpret and understand the results of clinical trials and observational studies, to project results of modifying screening programs and to estimate cost-effectiveness. The limitations of modeling as a method of gaining reliable information are reviewed; the most important potential sources of uncertainty, and how they are dealt with, are discussed. New applications of microsimulation in the field of breast cancer control are mentioned as possible future directions.

AB - Microsimulation modeling was introduced to the social sciences in the 1950s, but did not play any significant role in health care until the 1980s. The rapid growth and plunging cost of computing power in that era supported a sustained penetration of simulation modeling into health services research and policy analysis. In this chapter we provide an overview of how modeling of breast cancer screening is done and review how microsimulations have been used to interpret and understand the results of clinical trials and observational studies, to project results of modifying screening programs and to estimate cost-effectiveness. The limitations of modeling as a method of gaining reliable information are reviewed; the most important potential sources of uncertainty, and how they are dealt with, are discussed. New applications of microsimulation in the field of breast cancer control are mentioned as possible future directions.

KW - Breast cancer

KW - Health policy analysis

KW - Health services research

KW - Mammography

KW - Microsimulation model

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=84969642653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969642653&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-802209-2.00005-X

DO - 10.1016/B978-0-12-802209-2.00005-X

M3 - Chapter

SN - 9780128024942

SN - 9780128022092

SP - 103

EP - 132

BT - Breast Cancer Screening: An Examination of Scientific Evidence

PB - Elsevier Inc.

ER -